Targeting ineffective hematopoiesis in myelodysplastic syndromes.
Patnaik MM, Santini V.
Am J Hematol. 2022 Feb 1;97(2):171-173. doi: 10.1002/ajh.26416. Epub 2021 Nov 28.
Mitochondrial Fragmentation Triggers Ineffective Hematopoiesis in Myelodysplastic Syndromes.
Aoyagi Y, Hayashi Y, Harada Y, Choi K, Matsunuma N, Sadato D, Maemoto Y, Ito A, Yanagi S, Starczynowski DT, Harada H.
Cancer Discov. 2022 Jan;12(1):250-269. doi: 10.1158/2159-8290.CD-21-0032. Epub 2021 Aug 30.
Epidemiology and Pathogenesis of Myelodysplastic Syndrome.
Rotter LK, Shimony S, Ling K, Chen E, Shallis RM, Zeidan AM, Stahl M.
Cancer J. 2023 May-Jun 01;29(3):111-121. doi: 10.1097/PPO.0000000000000665.
Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes.
Angelucci E, Cianciulli P, Finelli C, Mecucci C, Voso MT, Tura S.
Leuk Res. 2017 Nov;62:108-115. doi: 10.1016/j.leukres.2017.10.001. Epub 2017 Oct 5.
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia.
Mian SA, Philippe C, Maniati E, Protopapa P, Bergot T, Piganeau M, Nemkov T, Di Bella D, Morales V, Finch AJ, D'Alessandro A, Bianchi K, Wang J, Gallipoli P, Kordasti S, Kubasch AS, Cross M, Platzbecker U, Wiseman DH, Bonnet D, Bernard DG, Gribben JG, Rouault-Pierre K.
Sci Transl Med. 2023 Mar;15(685):eabn5135. doi: 10.1126/scitranslmed.abn5135. Epub 2023 Mar 1.
Αlpha-thalassemia: A practical overview.
Musallam KM, Cappellini MD, Coates TD, Kuo KHM, Al-Samkari H, Sheth S, Viprakasit V, Taher AT.
Blood Rev. 2024 Mar;64:101165. doi: 10.1016/j.blre.2023.101165. Epub 2024 Jan 3.
Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia.
Chlon TM, Stepanchick E, Hershberger CE, Daniels NJ, Hueneman KM, Kuenzi Davis A, Choi K, Zheng Y, Gurnari C, Haferlach T, Padgett RA, Maciejewski JP, Starczynowski DT.
Cell Stem Cell. 2021 Nov 4;28(11):1966-1981.e6. doi: 10.1016/j.stem.2021.08.004. Epub 2021 Sep 1.
Iron metabolism and iron disorders revisited in the hepcidin era.
Camaschella C, Nai A, Silvestri L.
Haematologica. 2020 Jan 31;105(2):260-272. doi: 10.3324/haematol.2019.232124. Print 2020.
Next-generation therapy for lower-risk MDS.
Sébert M.
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):59-64. doi: 10.1182/hematology.2023000520.
Ineffective erythropoiesis and osteoporosis in thalassemia: Mechanistic insights?
Means RT Jr.
Am J Med Sci. 2023 Aug;366(2):85-86. doi: 10.1016/j.amjms.2023.05.001. Epub 2023 May 4.
